Making headway in anticoagulant and antiplatelet therapy

被引:5
|
作者
Fareed, Jawed [1 ]
机构
[1] Loyola Univ, Med Ctr, Hemostasis & Thrombosis Res Labs, Maywood, IL 60153 USA
关键词
DABIGATRAN; ANTIDOTE; REVERSAL;
D O I
10.1038/nrcardio.2014.222
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite favourable results in pivotal clinical trials involving novel direct oral anticoagulants, vitamin K antagonists remain the most commonly prescribed anticoagulant. Newer oral anticoagulants are slated for a wide range of additional indications, and specific antidotes to neutralize associated bleeding complications are currently under development.
引用
收藏
页码:70 / U7771
页数:2
相关论文
共 50 条
  • [31] Antiplatelet and anticoagulant therapy in patients with giant cell arteritis
    Lee, Michael S.
    Smith, Scott D.
    Galor, Anat
    Hoffman, Gary S.
    ARTHRITIS AND RHEUMATISM, 2006, 54 (10): : 3306 - 3309
  • [32] Paradoxical thrombosis, part 2: anticoagulant and antiplatelet therapy
    Lippi, Giuseppe
    Favaloro, Emmanuel J.
    Franchini, Massimo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (03) : 367 - 373
  • [33] Oral anticoagulant and antiplatelet therapy and peripheral arterial disease
    Anand, Sonia
    Yusuf, Salim
    Xie, Changchun
    Pogue, Janice
    Eikelboom, John
    Budaj, Andrzej
    Sussex, Bruce
    Liu, Lisheng
    Guzman, Randy
    Cina, Claudio
    Crowell, Richard
    Keltai, Matyas
    Gosselin, Gilbert
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03): : 217 - 227
  • [34] Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
    ten Berg, JM
    Plokker, HWT
    Verheugt, FWA
    CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE, 2001, 2 (03): : 129 - 140
  • [35] Combination Anticoagulant and Antiplatelet Therapy in Atrial Fibrillation Patients
    Lip, Gregory Y. H.
    Lane, Deirdre A.
    REVISTA ESPANOLA DE CARDIOLOGIA, 2009, 62 (09): : 972 - 975
  • [36] Management of antiplatelet or anticoagulant therapy in endoscopy: A review of literature
    Maida, Marcello
    Sferrazza, Sandro
    Maida, Carlo
    Morreale, Gaetano Cristian
    Vitello, Alessandro
    Longo, Giovanni
    Garofalo, Vincenzo
    Sinagra, Emanuele
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2020, 12 (06): : 172 - 192
  • [37] Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation
    Falk, RH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 44 (08) : 1567 - 1569
  • [38] Pharmacogenetic considerations in therapy with novel antiplatelet and anticoagulant agents
    Yazbeck, Anthony
    Akika, Reem
    Awada, Zainab
    Zgheib, Nathalie K.
    PHARMACOGENETICS AND GENOMICS, 2024, 34 (03): : 61 - 72
  • [39] ANTIPLATELET AND ANTICOAGULANT-THERAPY DURING CORONARY THROMBOLYSIS
    FITZGERALD, DJ
    FITZGERALD, GA
    TRENDS IN CARDIOVASCULAR MEDICINE, 1991, 1 (01) : 29 - 35
  • [40] Prolonged double antiplatelet therapy vs association of antiplatelet and low dose of anticoagulant therapy: PEGASUS or COMPASS?
    Brunetti, Natale Daniele
    De Gennaro, Luisa
    Di Biase, Matteo
    Caldarola, Pasquale
    IJC HEART & VASCULATURE, 2019, 24